Thomas A. Hope
机构:University of California, San Francisco, University of California System, Fondazione IRCCS Istituto Nazionale dei Tumori, UCSF Helen Diller Family Comprehensive Cancer Center · ORCID:0000-0002-2228-5823
发表论文 429 篇 · 总被引 17687 次 · h-index 67
代表论文
- Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP) (2025 · Future Oncology · 被引 3)
- Prostate‐specific membrane antigen positron emission tomography/computed tomography imaging as a precision diagnostic at prostate cancer recurrence after radical prostatectomy: Modeling long‐term survival (2025 · Cancer · 被引 1)
- Supplementary Table S5 from Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial (2026)
- Supplementary Table S8 from Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial (2026)
- Supplementary Table S1 from Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial (2026)
- Supplementary Table S6 from Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial (2026)